Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron (December 22, 2016)

Contract Categories: Business Finance › Modification Agreements
Summary

Cyclacel Pharmaceuticals, Inc. and Paul McBarron have agreed to extend their existing agreement, originally dated January 2, 2014, through June 30, 2017. This document confirms the extension and requires Mr. McBarron's acknowledgment and signature to be effective. No other terms of the original agreement are changed by this extension.

Read More Arrow
EX-10.15 3 t1700098_ex10-15.htm EXHIBIT 10.15

 

Exhibit 10.15

 

CYCLACEL PHARMACEUTICALS, INC.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

 

December 22, 2016

 

Mr. Paul McBarron

c/o Cyclacel Pharmaceuticals, Inc.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

 

Dear Mr. McBarron:

 

Reference is made to the agreement between us (the “Agreement”) made as of January 2, 2014. This will confirm our agreement to extend the Agreement through the period ended June 30, 2017. Please confirm your agreement to the foregoing by signing below in the space provided.

 

  Sincerely,
   
  CYCLACEL PHARMACEUTICALS, INC.
     
  By: /s/ Spiro Rombotis
  Name: Spiro Rombotis
  Title: President & CEO

 

ACKNOWLEDGED AND AGREED:  
   
/s/ Paul McBarron  
Paul McBarron